Pay in 4 interest-free payments of $5.89 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Managing constipation whilst on GLP-1 treatments Dietary strategies Increase fibre intake gradually to 25-30g daily through fruits, vegetables, whole grains, and legumes Stay well-hydrated with at least 2-3 litres of water daily Consider psyllium husk or other soluble fibre supplements if dietary fibre is insufficient Magnesium supplements can have a laxative effect and relieve constipation Include probiotic-rich foods like yoghurt, kefir and fermented vegetables Limit foods that may worsen constipation such as processed foods, cheese, and white bread Physical activity approaches Try specific yoga poses known to stimulate digestive motility Practice abdominal massage in a clockwise direction Maintain an active lifestyle with regular movement throughout the day and at least 30 minutes regular exercise Consider a short walk after meals to stimulate digestion Bathroom habits Establish a regular toileting routine at the same time each day Dont ignore the urge to have a bowel movement Use proper positioning with knees higher than hips (a footstool can help) Allow sufficient unhurried time in the bathroom Practice relaxation techniques to reduce tension during bowel movements Medical interventions Over-the-counter osmotic laxatives like polyethylene glycol (Movicol) for occasional relief Stool softeners such as docusate sodium (Dioctyl) if stools are particularly hard Bulk-forming laxatives such as ispaghula husk (Fybogel)
Most sleep supplements in pill or capsule form lose a significant portion of their active ingredients during digestion
7 , eabk1023 (2021)
How to manage it: Increase fiber intake by eating more vegetables, legumes, and whole grains
Per week: 14 swabs (2/day) 8 weeks: 112 swabs recommend 2 100-count boxes 12 weeks: 168 swabs recommend 2 100-count boxes 16 weeks: 224 swabs recommend 3 100-count boxes Protocol Overview Goal: Enhance skin pigmentation via melanocortin receptor activation Schedule: Daily injections for 68 weeks (loading phase) Maintenance: 12 injections per week Dose Range: 2501750 mcg daily Cycle Length: 812 weeks typical Dosing Protocol Start at 200250 mcg daily Increase gradually every 12 weeks Target 5001000 mcg daily by Weeks 48 Transition to maintenance dosing after initial phase Inject at a consistent time and rotate sites Storage Instructions Lyophilized: Store at 20C in a dry, dark environment Reconstituted: Refrigerate at 28C Avoid repeated freezethaw cycles Use within 23 weeks for best stability Allow vial to reach room temperature before opening Important Notes Key considerations for consistency, handling, and research accuracy
CT-868 is an injectable GLP-1/GIP dual agonist in development as an adjunct therapy to insulin for T1D
